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Objective: Reconstruction of branch pulmonary arteries (PAs) can be challenging in redo
congenital heart surgeries. Treatment options like percutaneous stent implantation and
surgical patch angioplasty may yield suboptimal results. We present our experience with
hybrid intraoperative stenting which may be an effective alternative option.
Methods: We retrospectively analyzed data of all patients with PA stenosis who underwent
intraoperative PA branch stenting in our institution between January 2011 and December
2012.
Results: Ten patients [6 females, median age 10 (1.4 to 37) years], underwent hybrid stenting
of the PA. Primary cardiac diagnoses were pulmonary atresia with ventricular septal defect
(VSD) in three patients, pulmonary atresia with intact ventricular septum in two, Tetralogy
of Fallot (TOF) in one, Double outlet right ventricle (DORV) with pulmonary stenosis (PS) in
one, complex single ventricle in two and VSD with bilateral branch PA stenosis in one
patient. Concomitant surgeries were revision/reconstruction of RV-PA conduit in 4, Fontan
completion in 4, repair of TOF with conduit placement in 1 and VSD closure in 1 patient.
The left PA was stented in 7, the right in 2 and both in 1, with a total of 11 stents. There
were no complications related to stent implantation. Two early postoperative deaths were
unrelated to stent implantation. At mean follow-up period of 14.8 (12e26) months, stent
position and patency were satisfactory in all survivors. None of them needed repeat dila-
tation or surgical reintervention.
Conclusion: Hybrid stenting of branch PA is a safe and effective option for PA reconstruction
in redo cardiac surgeries. With meticulous planning, it can be safely performed without
fluoroscopy.
Copyright ª 2013, Cardiological Society of India. All rights reserved.5; fax: þ91 44 26565150.
l.com (A. Sridhar).
2013, Cardiological Society of India. All rights reserved.
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Branch pulmonary artery (PA) stenosis could be congenital
occurring either as an isolated anomaly or in association with
other congenital heart defects. It can also occur following a
previous attempt at surgical repair. PA reconstruction in these
patients could be accomplished by surgical patch angioplasty,
transcatheter stenting or hybrid intraoperative stent implan-
tation.1 In cases of complex congenital heart disease (CHD)
requiring redo surgeries, surgical patch angioplasty may be
difficult and yield suboptimal results. Transcatheter stenting
may also be difficult in these patients due to complex anatomy
and difficult vascular access.
The limited data available on the outcome of intra-
operative stent implantation in redo surgeries is that of
developed countries only.2e22 We present our experience in
successfully performing hybrid stenting in redo congenital
cardiac surgeries without using fluoroscopy in a series of ten
patients during a two year period.2. Technique
Intraoperative stenting procedures were performed by pedi-
atric cardiac surgeons in collaboration with pediatric inter-
ventional cardiologists. All procedures were performed under
hypothermic cardiopulmonary bypass and none of the pa-
tients required circulatory arrest. Preoperatively, eitherFig. 1 e Intraoperative images of patient number 2 e [A] showing
(arrow) in the Right pulmonary artery. [B] shows stents with fla
pulmonary arteries. Apart from suturing the proximal end of th
together across the confluence posteriorly (arrow) to prevent m
after excision of the stenosed right ventricle to pulmonary arte
bioprosthetic valve (arrow) in the pulmonary position [D].conventional angiography or computerized tomographic (CT)
pulmonary angiography was done to define the size, area, and
length of PA stenosis. The size of stent and delivery balloon
were determined based on calibrated measurements from
preoperative angiographic images, where the branch PA
ostium & the distal bifurcation site were used as reference
points. In addition, diameter of the stenosed segment of the
branch pulmonary artery was reconfirmed intra operatively
by the surgeon using a Hegar dilator that could be introduced
into the PA. Only balloon-expandable stents were used. A
guide wire was advanced by the surgeon under direct visual-
ization into the PA branch, and the stent/balloon was posi-
tioned in the branch PA by the surgeon over this guide wire.
The balloon was inflated to the maximum recommended
pressure by the interventional cardiologist. Intraoperative
fluoroscopy was not used. It was difficult to assess the uni-
form dilatation of the stent and the balloon in the operating
room without the aid of fluoroscopy. Following inflation,
surgeons assess the full expansion of the stent by inspection
and gentle palpation of stent and by passing an appropriate
sized Hegar dilator through the stented vessel. The proximal
end of the stentwas flaredmildly by rotating a large size Hegar
dilator and sutured to the PA to prevent stent migration
[Fig. 1]. At the end of surgery, intraoperative transesophageal
echocardiography was also utilized to confirm appropriate
stent position. In the immediate postoperative period and at
discharge, chest X-ray and color Doppler echocardiography
were done to assess the stent position, size and gradients in
the PAs. Doppler gradients can be highly fallacious especiallydeployment of the stent mounted on high pressure balloon
red proximal ends seen in the origin of both branch
e stents to the pulmonary artery, the two stents were tied
igration and obstruction. Suturing of on lay patch (arrow)
ry (RV-PA) conduit [C] was followed by implantation of
Fig. 2 e Representative pulmonary angiography before and after hybrid intraoperative stenting procedure in two patients.
A1 & A2: Angiogram of a 9 year-old-girl (Patient 1) who underwent change of right ventricle to pulmonary artery (RV-PA)
conduit and right pulmonary artery stenting. B1 & B2: Angiogram of a 13-year-old boy (Patient 7) who underwent extra
cardiac Fontan completion and stenting of LPA origin. In both the patients, the stents (arrows) are in good position with
complete expansion and there is improved peripheral arborization.
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diographic evidence of good position and uniform expansion
of the stent as well as absence of very high Doppler gradient to
assess the status of stent.
Conventional angiography and CT pulmonary angiography
were performed during follow-up [Fig. 2].3. Patients and method
Between January 2011 and December 2012, hybrid intra-
operative stent implantation was done in 10 consecutive pa-
tients for severe branch PA stenosis. The patient
characteristics are listed in Table 1. There were 6 females and
4 males and the median age was 10 (1.4e37) years. Primary
cardiac diagnoses were pulmonary atresia with intact ven-
tricular septum in two patients, pulmonary atresia with ven-
tricular septal defect (VSD) in three, Tetralogy of Fallot in one,
Double outlet right ventricle with VSD and pulmonary steno-
sis (PS) in one, Complex single ventricle with transposition of
great arteries and severe pulmonary stenosis in one, Unbal-
anced atrioventricular canal defect in one and VSD with
bilateral branch PA stenosis in one patient. All patients un-
derwent redo cardiac surgery for complex CHD. Stenting was
combinedwith repair of TOFwith right ventricle to pulmonaryartery (RV-PA) conduit placement in one patient, revision/
reconstruction of RV-PA conduit in four, Fontan completion in
four and VSD closure in one patient. All patients had elective
stenting procedure and a total of 11 stents were deployed.
Seven patients received stent in left PA, two in right PA; and
one in both branch PA’s. Preoperative imaging (cardiac cath-
eterization, CT scan, or MRI) helped to determine appropriate
stent length, stent position to avoid side-branch “jailing”, and
the appropriate stent diameter to achieve complete relief of
the PA stenosis without over dilation. Intraoperative pulmo-
nary artery stenting was performed on an elective basis in all
patients. The details of stenting procedure are provided in
Table 2. Maximum stent diameters ranged from 8 to 12 mm.
The median balloon diameter was 12 mm (range 8e16 mm).4. Results
During stent implantation and in the immediate postoperative
period, there were no complications such as pulmonary artery
tear/dissection, stent thrombosis or distal stent migration.
Two patients died in the immediate postoperative period, not
related to the stent implantation. One is a 10-year-old girl with
pulmonary atresia andVSD,who previously underwent RV-PA
conduit placement with intraoperative stent implantation in
Table 1 e Preoperative patient characteristics and postoperative outcome measures (n[ 10).
No Age (Yrs)/Sex Primary cardiac
diagnosis
Previous surgery Concomitant surgery Follow-up period
in months
1 9/F PA-VSD RMBTS & LMBTS;
ICR [RV-PA conduit & Redo
PA plasty]
RV e PA conduit [PTFE on lay patch &
bioprosthetic pulmonary valve].
26
2 10/F PA-VSD RMBTS; ICR [RV-PA conduit,
intraoperative RPA stenting].
Transcatheter LPA stenting.
RV e PA conduit [PTFE on lay patch &
bioprosthetic pulmonary valve].
Expired
3 9/M PA-IVS Pott’s shunt; Right BDG. Extra cardiac completion of Fontan. 20
4 9/F UAVCD/PS LCBTS; Right BDG. Extra cardiac Fontan completion,
PA confluence plasty.
18
5 18/F PA-VSD RMBTS, ICR [RV-PA conduit ] RV-PA conduit [PTFE on lay patch &
bioprosthetic pulmonary valve].
16
6 10/F SV/TGA/PS Right BDG. Extracardiac Fontan completion. 15
7 13/M PA-IVS Right BDG. Extracardiac Fontan completion. 13
8 19/F TOF/PS LMBTS ICR [VSD closure, RV-PA conduit] 12
9 1.4/M VSD/PS PA banding. VSD Closure, PA debanding and
confluence plasty.
12
10 37/M DORV/VSD/PS ICR [RV e PA conduit];
Conduit replacement.
RV e PA conduit [PTFE on lay patch &
bioprosthetic pulmonary valve].
Expired
PA-VSD e Pulmonary atresia with Ventricular septal defect, PA-IVS e Pulmonary atresia with intact ventricular septum, UAVCD e Unbalanced
Atrioventricular canal defect; PS e Pulmonary stenosis, SV e Single ventricle, TGA e Transposed great arteries, PS e Pulmonary stenosis, DORV
e Double outlet right ventricle, RPA e Right Pulmonary artery, LPA e Left pulmonary artery, ICR e Intra cardiac repair, RMBTS e Right modified
Blalock Taussig shunt, LMBTS e Left modified Blalock Taussig shunt, LCBTS e Left classical Blalock Taussig shunt, RV-PA -Right ventricle to
Pulmonary artery shunt, BDG e Bidirectional glenn shunt, PTFE e Poly tetrafluoro ethylene.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 5e5 148RPA at 5 years of age followed by transcatheter LPA stenting
procedure. She underwent conduit replacement surgery with
intraoperative replacement of stents in both branch PAs. She
died three weeks postoperatively from severe neurological
complication characterized by paraplegia, unresponsiveness,
seizures and electrolyte imbalance. Her CT brain showed
extensive hemorrhagic infarct.
The other patient was a 37-year-old male with pulmonary
atresia and VSDwho previously had RV-PA conduit placement
at 2 years of age and replacement of conduit at 14 years of age.
He presented with features of RV failure and was very symp-
tomatic (Class III). His preoperative echocardiography and
cardiac catheterization were suggestive of severe conduit
stenosis, severe LPA origin stenosis, severe RV dilatation and
dysfunction. He underwent change of RV-PA conduit using a
24 mm PTFE (poly tetrafluoro ethylene) tube and insertion of
25 mm CE Perimount valve. Although there was no difficulty
in coming off bypass, he developed severe hypotension and
bradycardia within 2 h of shifting to the intensive care unit.
ECMO support was initiated immediately but he died on the
third postoperative day. Eight patients were successfully dis-
charged after the surgical intervention with concomitant
stent implantation. Stent position and patency was evaluated
by angiography in 2 patients, CT angiography in one and by
chest X-ray and echocardiography color Doppler in all other
patients at the time of discharge. There was no displacement
of stent and no stent occlusion in any of the cases in the im-
mediate postoperative period.
One child among the eight survivors (patient no.3 in Tables
1 and 2) developed dense right sided hemiplegia with aphasia
during the immediate postoperative period. This child under-
went Fontan completion & intraoperative stenting of left pul-
monaryartery.HisCTbrain showed large thrombotic infarct in
the left middle cerebral artery. The neurological complicationwas considered unrelated to the stenting procedure as there
was no difficulty during the stenting procedure and post pro-
cedure assessment showed good position and patency of the
stent. At a mean follow-up period of fourteen months (range
12e26 months), there were no late deaths and none required
reintervention. All patients had follow up echocardiograms
and chest x-rays. Cardiac catheterization was performed in
twopatients andCTpulmonaryangiographywasperformed in
three patients during this period.
In addition to imaging studies, two patients underwent
before discharge. The lung perfusion scans were done before
and after the procedure in both the patients. The perfusion
scans showed improved perfusion on the side of stented
pulmonary artery and the findings correlated well with the
imaging studies.
Among the remaining three survivors in whom follow up
imaging studies could not be done early due to social rea-
sons, we have confirmed the stent position, uniform expan-
sion and flow by echocardiography and these patients are
hemodynamically stable with normal RV pressure.
All survivors had increase in PA diameter with normal
value Z score during follow up assessment. Patients who had
redo conduit insertion had a significant improvement in RV
systolic pressure following the procedure. The RV systolic
pressure to systemic pressure ratio reduced significantly from
a mean of 78 (54e98) mm Hg to a mean of 45 (28e52) mmHg.
The reduction in RV systolic pressuremay be partly due to the
concomitant RV outflow tract surgeries.5. Comments
Hybrid branch PA stenting is an option for PA reconstruction
when (a) percutaneous transcatheter stenting is technically
Table 2 e Details of intraoperative stenting procedure (n[ 10).
Patient PA
stented
Site of stenosis Balloon diameter
(mm) and type
Stent maximum expansion
dimension and type
Number
of stents
Difficulty or complications during stenting Follow-up
investigations
1 RPA Severe proximal &
entirely hypoplastic
Premounted 10/37 mm Chromaxx stent (BARD)# 1 Nil Angiography
2 Both Restenosis of
previous stents
12/40 mm Z med
Balloon $
12/29 mm (RPA) & 10/29 mm (LPA)
Cordis Palmaz peripheral vascular
stent*
2 Severe in-stent restenosis noted. Both stents were
removed and fresh stents placed and it was a difficult
stenting of the previously stented arteries. The stents
were tied together posteriorly across the confluence to
facilitate future transcatheter interventions. Expired
in early postoperative period due to severe neurological
complication.
Echocardiography & CXR
3 LPA Proximal & mid
segment
12/40 mm Z med
Balloon $
12/29 mm Cordis Palmaz peripheral
vascular stent*
1 No complications during stenting.
Neurological complication e dense right hemiplegia
in the immediate postoperative period despite
reduced CPB time. Survived.
CT Angiography
4 LPA Proximal & mid
segment
Premounted 12/29 mm Cordis Palmaz peripheral
vascular stent*
1 Nil Echocardiography & CXR
5 LPA Proximal and mid
segment
14/30 mm BSC
Diamond balloon##
12/27 mm Cordis Palmaz peripheral
vascular stent*
1 Conduit was heavily calcified and fibrosed. Difficulty
in accessing the branch PA opening as there were
dense adhesions and the patient was very obese
(98 kg). LPA opening was small and probe entered
in oblique direction. RPA was good sized.
CT Angiography
6 LPA Proximal & mid
segment. Entirely
small PA
Premounted 10/27 mm ev3 Visi pro stent** 1 Nil Echocardiography & CXR
7 LPA Proximal & mid
segment
12/30 mm ev3
Balloon**
10/29 mm Cordis Palmaz peripheral
vascular stent*
1 Nil Angiography
8 LPA Proximal and mid
segment severe
stenosis
Premounted 10/27 mm ev3 Visi pro stent** 1 Nil Echocardiography & CXR
9 RPA Proximal & mid
segment
Premounted 8/27 mm ev3 Visi pro stent** 1 Nil CT Angiography
10 LPA Proximal stenosis &
diffuse hypoplasia
Premounted 10/56 mm Biohonk dynamic stent*** 1 No difficulty in stenting. Early postoperative death
due to Severe RV dysfunction (Fibrous RV/Low cardiac
output syndrome).
Echocardiography & CXR
# e Bard Peripheral Vascular Inc, Tempe, AZ, USA, * e Cordis Cashel, Cashel, Co Tipperary, Ireland, ** e Medi mark Europe, SARL BR 2332,France, *** e Ackerstrasse 6,8180 Bulach, Switzerland, $ e
Numed Inc, Hopkinton, NY, ## e Boston scientific corporation, Water town, MA RPA e Right pulmonary artery, LPA e Left pulmonary artery, CT e Computerized tomography, ECMO e Extracorporeal
membrane oxygenation.
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needed and surgical PA plastymay be difficult or hazardous1e4
or (c) when rescue needed following complications of percu-
taneous stenting such as stent migration, bleeding, dissection
etc.5,6 All patients in our group needed pulmonary artery
reconstruction and concomitant redo cardiac surgery and
hence transcatheter PA stenting was avoided as a separate
invasive procedure. The primary aim of performing intra-
operative stent implantation in this group was to reduce the
complexity of surgical repair, to shorten cardiopulmonary
bypass time and to reduce the risk of late restenosis that can
occur after surgical plasty.
Intraoperative stenting has many advantages in patients
with complex CHD undergoing redo cardiac surgeries besides
reducing the number of invasive procedures. In addition,
transcatheter stenting of stenosed branch PAs may be tech-
nically difficult in these patients due to one or more of the
following factors: (a) absent or difficult vascular access, (b)
severe right ventricular outflow/conduit obstruction, or
tortuous and distorted branch pulmonary arteries, (c) pres-
ence of previously implanted prosthetic pulmonary or
tricuspid valve, (d) marginal hemodynamics or ventricular
dysfunction especially in the early postoperative period,
which may not allow manipulation of large sheaths and
splinting of the valves, (e) bilateral PA branch stenosis with
closely placed ostia when the stent within one ostiummay jail
the other ostium, (f) adult CHD patients requiring large bal-
loons and sheaths, (g) previously implanted stents with severe
in-stent restenosis which are difficult to redilate, and (h)
critically stenosed or completely occluded branch PAs which
are hard to traverse with catheters and stent. These pro-
cedures can be safely performed as hybrid stenting in the
operating room under cardiopulmonary bypass support.2,3,7
Surgical patch angioplastymay also be challenging in these
patients and hybrid intraoperative stenting could be a better
alternative approach for many reasons: (a) Dissection and
access is complicated by adhesions, scarring, compression,
bleeding and excessive collateral flow.8 This directly leads to
longer duration of surgery, prolonged CPB time and need for
circulatory arrest. Hybrid intraoperative stenting on the other
hand is much safer, quicker and easier to perform, effectively
reducing the CPB time.5,9 As the stent is placed with direct
visualization extensive dissection is usually not needed. (b)
Even anatomical sites that are difficult to access for patch
angioplasty such as lobar branch stenosis, LPA stenosis in a
redo surgical situation and RPA behind aorta, can be more
easilymanaged by hybrid approach.10 Eight out of ten patients
in our study had LPA stenosis. (c) Sometimes the stenosis,
especially in a redo situation is complex with severe fibrosis,
calcification, hypoplasia and associated with dilatation or
external compression. Hybrid stenting procedure may be a
better option in these situations, especially in those with hy-
poplastic PA.11,12 Use of stents will also allow serial dilatation
of the small artery to a larger diameter.9,16 Presence of fibrous
scarringmay be an advantage in hybrid stenting as it provides
support during stent expansion.5,10,13,14 Extensive dissection
around the PA branch is in fact not advisable in hybrid
stenting to prevent thinning and rupture of the artery. (d)
Injury to the phrenic nerve, lymphatics and other vascular
structures which can occur with dissection around PAbranches in redo surgeries can be avoided in hybrid stenting.
(e) Significant restenosis or complete occlusion following
surgical angioplasty can occur in the early postoperative
period in some patients, requiring percutaneous stent place-
ment.23,24 However transcatheter stenting may be hazardous
in the early postoperative period with fresh suture lines.15 (f)
Autologous pericardium may not be available for patch an-
gioplasty after multiple previous surgeries. (h) In cases of
completely occluded or long segment PA stenosis where there
is a long distance to reach the distal artery, reconstruction
may be impossible with surgical patch angioplasty. Hybrid
stenting may be the only possible treatment option in these
situations.17
Complications associated with stenting can be better
handled in the operating room while on CPB support than in
the catheterization laboratory.4,5,11,12,25e27 The various com-
plications of hybrid stent implantation include (a) PA dissec-
tion or rupture, (b) stent migration, (c) incomplete expansion
of stent, (d) stent thrombosis, (e) obstruction of smaller PA
branches, (f) stent restenosis, (g) inhibition of PA growth, (h)
transient pulmonary edema, (i) airway compression. Stent
migration can be prevented by flaring the proximal end and
suturing it to the pulmonary artery.5 Inflation of balloon to the
maximum recommended pressure, multiple inflations and
redilating the proximal and distal end of the stent are the
measures to ensure adequate stent expansion. Aspirin ther-
apy is recommended postoperatively to prevent stent
thrombosis. Careful review of preoperative angiograms,
proper calibrated measurement, and careful selection of stent
length and size should help to prevent potential entrapment
of side branches. Over inflation of the balloon while deploying
the stents should be avoided to prevent airway compression.
Ideally, intraoperative stenting should be performed in a
hybrid suite with capability for biplane fluoroscopy and
angiography. In our series, all the cases have been restricted to
the proximal and mid portion stenting to avoid problems of
stent malposition, dissection, jailing of side branches etc.
When fluoroscopy is not available, post procedural visual in-
spection and gentle palpation of the pulmonary artery can be
performed by the surgeons to assess correct deployment of
the stent.1 Operators however, should have a low threshold
for performing exit angiography after the procedure.10,12,18,19
The potential adverse long-term effect of a stent on future
PA growth and making it less amenable to patch plasty at a
later date in view of increased tissue friability are important
concerns.4,11 Cautious patient selection, use of re-expandable
stents that can undergo repeat percutaneous dilatation if
needed in the future to accompany growth of the patient will
resolve these issues.11,13,16,18
The long-term concern is the need for re-intervention
previously reported to be 26% within 15 months median
follow up4 and 25%within 2e24months follow up.12 Angtuaco
et al16 reported re-intervention rate as high as 49% with the
longest follow up so far (mean of 7.6 years). They found age
less than two years, weight less than 10 kg, and initial post-
inflation stent diameter less than 10 mm in diameter as sig-
nificant factors associated with a higher risk of re-
intervention. In case of a 1.4 year old child in our study
group (case No. 9 in Tables 1 and 2), we used an 8 27 mm ev3
Visi Pro premounted stent for RPA origin stenosis. The Right
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 5e5 1 51pulmonary artery measured 3 mm at the stenosis and 6.4 mm
distally in CT pulmonary angiography. Hence we chose to
expand the stent to 8 mm diameter. Our first preference is to
use a stent which can be expanded to a larger diameter in
future if necessary, as the child grows. In this case we had to
use a premounted Visi Pro stent due to non-availability of
larger stents. Moreover bench testing has shown that an 8mm
Visi Pro stent can be expanded later, up to a diameter of
12 mm without damaging the stent.28 The mean follow up
period in our series is short similar to report by Coles et al3
but there was no reintervention among the eight survivors.
Further long term follow up of these patients is needed to
comment on our incidence of reintervention.
We conclude that hybrid intraoperative stenting of branch
pulmonary arteries is an effective method of pulmonary ar-
tery reconstruction and has many advantages in patients
undergoing redo cardiac surgeries. The hybrid approach may
result in reduced risk, less invasive procedures, and improved
outcome. With meticulous preoperative planning it can be
safely performed in the operating room without fluoroscopy.Conflicts of interest
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